Sana Habib, MD
Allergy & Immunology · Washington, DCNPI 1629431747
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AstraZeneca at 26.5% of the total. 2025 is the largest year on record at $2,762, more than ten times the $260 reported in 2022. That places this record below the midpoint for allergy & immunology clinicians in DC, where the typical reported total is $4,220.
Across 115 payments — averaging $32.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Sanofi$971
- Regeneron Healthcare Solutions, Inc.$243
- Amgen$234
- Pfizer$208
- Novartis$196
- plus $920 from 15 others
What the payments were for
- Food & beverage$3,67597%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 30 | $1,002 |
| Sanofi | 29 | $971 |
| Regeneron Healthcare Solutions, Inc. | 8 | $243 |
| Amgen | 5 | $234 |
| Pfizer | 5 | $208 |
| Novartis | 7 | $196 |
| GSK | 6 | $164 |
| CSL Behring | 4 | $118 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $113 |
| Daiichi Sankyo Inc. | 1 | $100 |
| Biocryst US Sales Co., LLC | 3 | $94 |
| Optinose US, Inc. | 3 | $67 |
| Blueprint Medicines Corporation | 1 | $51 |
| Genentech USA, Inc. | 2 | $50 |
| Grifols USA, LLC | 1 | $29 |
| Alk-abello, Inc | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Galderma Laboratories, L.p. | 1 | $23 |
| Lilly USA, LLC | 1 | $23 |
| Regeneron | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,775 in reported general payments places this provider in the 45th percentile of 20 allergy & immunology providers in District of Columbia.
See all allergy & immunology providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 71 | $2,597 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 13 | $1,178 |
| Fluticasone Propionate | 68 | $1,093 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 21 | $1,071 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $1,059 |
| Montelukast Sodium | 29 | $493 |
| Ipratropium Bromide | 22 | $416 |
| Famotidine | 24 | $244 |
| Omeprazole | 25 | $220 |
| Levocetirizine Dihydrochloride | 12 | $191 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Washington
- Autumn BurnetteWashington$2.3M
- Lawrence DubuskeWashington$1.8M
- Eliane Abou-JaoudeWashington$66K
- Daniel EinWashington$52K
- Olabunmi AgboolaWashington$13K
- Dan BrodyWashington$9K
- Michael KellerWashington$9K
- Maribel Mamonluk-ChuaWashington$7K
- Sebastian Ochoa GonzalezWashington$6K
- Janine van LanckerWashington$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.